Study of DONQ52 in Active Celiac Disease

NCT07239336 · clinicaltrials.gov ↗

PHASE2

Phase

RECRUITING

Status

92

Enrollment

INDUSTRY

Sponsor class

Conditions

Celiac Disease

Interventions

DRUG: Placebo DONQ52
DIETARY_SUPPLEMENT: Simulated Inadvertent Gluten Exposure (SIGE) capsule
DRUG: DONQ52
DIETARY_SUPPLEMENT: Simulated Inadvertent Gluten Exposure (SIGE) capsule

Sponsor

Chugai Pharmaceutical